Arkema Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Arkema wird ein jährliches Gewinn- und Umsatzwachstum von 20.6% bzw. 4.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 21.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.2% betragen.

Wichtige Informationen

20.6%

Wachstumsrate der Gewinne

21.5%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	11.8%
Wachstumsrate der Einnahmen	4.4%
Zukünftige Eigenkapitalrendite	11.2%
Analystenabdeckung	Good
Zuletzt aktualisiert	15 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Arkema S.A. (EPA:AKE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 09

Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 05

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 02

Recent updates

Arkema S.A. (EPA:AKE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 09

Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality

Aug 08

Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 05

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 02

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Dec 30

An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Dec 15

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Nov 29

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Sep 07

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Aug 20

Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Aug 02

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

May 28

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

May 13

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

May 09

Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Apr 24

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Apr 05

Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Feb 26

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Feb 14

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Jan 30

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Jan 14

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Nov 02

At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Oct 11

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Jul 19

What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?

Jul 04

If You Like EPS Growth Then Check Out Arkema (EPA:AKE) Before It's Too Late

Jun 03

Arkema's (EPA:AKE) Upcoming Dividend Will Be Larger Than Last Year's

May 10

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Apr 25

Is There An Opportunity With Arkema S.A.'s (EPA:AKE) 47% Undervaluation?

Apr 24

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.00

Apr 10

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Mar 27

Gewinn- und Umsatzwachstumsprognosen

ENXTPA:AKE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	10,438	727	718	1,418	14
12/31/2025	10,004	636	534	1,257	16
12/31/2024	9,560	493	401	1,107	15
9/30/2024	9,493	346	472	1,176	N/A
6/30/2024	9,425	342	556	1,235	N/A
3/31/2024	9,331	349	570	1,214	N/A
12/31/2023	9,514	402	638	1,272	N/A
9/30/2023	9,799	393	583	1,267	N/A
6/30/2023	10,445	503	688	1,382	N/A
3/31/2023	11,187	752	805	1,489	N/A
12/31/2022	11,550	949	789	1,496	N/A
9/30/2022	11,543	1,050	656	1,347	N/A
6/30/2022	10,969	1,073	298	1,013	N/A
3/31/2022	10,180	1,498	166	914	N/A
12/31/2021	9,519	1,293	152	915	N/A
9/30/2021	9,004	1,212	193	905	N/A
6/30/2021	8,515	1,057	457	1,132	N/A
3/31/2021	8,022	350	523	1,163	N/A
12/31/2020	7,884	304	510	1,115	N/A
9/30/2020	7,952	312	680	1,288	N/A
6/30/2020	8,259	365	615	1,232	N/A
3/31/2020	8,611	422	543	1,161	N/A
12/31/2019	8,738	491	665	1,300	N/A
9/30/2019	8,892	561	596	1,247	N/A
6/30/2019	8,843	590	614	1,263	N/A
3/31/2019	8,859	633	564	1,201	N/A
12/31/2018	8,816	674	438	1,029	N/A
9/30/2018	8,566	685	433	961	N/A
6/30/2018	8,418	653	N/A	943	N/A
3/31/2018	8,346	594	N/A	1,005	N/A
12/31/2017	8,326	543	N/A	1,008	N/A
9/30/2017	8,221	492	N/A	904	N/A
6/30/2017	8,040	446	N/A	877	N/A
3/31/2017	7,794	433	N/A	833	N/A
12/31/2016	7,535	394	N/A	821	N/A
9/30/2016	7,443	390	N/A	955	N/A
6/30/2016	7,551	355	N/A	863	N/A
3/31/2016	7,705	341	N/A	885	N/A
12/31/2015	7,683	285	N/A	858	N/A
9/30/2015	7,354	263	N/A	640	N/A
6/30/2015	6,886	226	N/A	587	N/A
3/31/2015	6,300	144	N/A	481	N/A
12/31/2014	5,952	167	N/A	507	N/A
9/30/2014	5,932	161	N/A	520	N/A
6/30/2014	5,949	202	N/A	577	N/A
3/31/2014	6,058	275	N/A	523	N/A
12/31/2013	6,098	168	N/A	467	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: AKEDas prognostizierte Gewinnwachstum (20.6% pro Jahr) liegt über der Sparquote (1.4%).

Ertrag vs. Markt: AKEDie Erträge des Unternehmens (20.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt French (12.5% pro Jahr).

Hohe Wachstumserträge: AKEEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: AKEDie Einnahmen des Unternehmens (4.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt French (5.6% pro Jahr).

Hohe Wachstumseinnahmen: AKEDie Einnahmen des Unternehmens (4.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: AKEDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.2%).

Arkema Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Arkema S.A. (EPA:AKE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Consensus EPS estimates fall by 11%

Consensus EPS estimates fall by 20%

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Consensus EPS estimates increase by 11%

Recent updates

Arkema S.A. to Report First Half, 2025 Results on Jul 31, 2025

Arkema S.A. (EPA:AKE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Third quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Arkema S.A. to Report Q1, 2025 Results on May 07, 2025

Arkema Launches Ethyl Acrylate Based Entirely on Bioethanol

Arkema S.A. Announces Management Changes

Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality

Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Arkema S.A. to Report Fiscal Year 2024 Results on Feb 27, 2025

We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt

Consensus EPS estimates fall by 11%

Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of €3.50 per share

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Arkema S.A. (ENXTPA:AKE) agreed to acquire The Dow Chemical Company from Dow Inc. (NYSE:DOW) for an enterprise value of $150 million.

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50

Is Arkema (EPA:AKE) A Risky Investment?

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50

Dividend increased to €3.50

Consensus EPS estimates fall by 20%

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Full year 2023 earnings: EPS misses analyst expectations

Arkema S.A. to Report Q2, 2024 Results on Aug 01, 2024

Arkema S.A. (ENXTPA:AKE) acquired an unknown minority stake in Tiamat.

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Arkema S.A. (ENXTPA:AKE) acquired Arc Bulding Products.

Arkema S.A. (ENXTPA:AKE) completed the acquisition of 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity.

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Arkema S.A. to Report Q1, 2024 Results on May 07, 2024

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Arkema S.A., Annual General Meeting, May 15, 2024

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Second quarter 2023 earnings: EPS in line with expectations, revenues disappoint

Now 21% undervalued

Arkema S.A. (ENXTPA:AKE) agreed to acquire a 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity for approximately €730 million.

Arkema S.A. (ENXTPA:AKE) agreed to acquire a 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity for approximately €730 million.

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates increase by 11%

Arkema S.A. agreed to acquire Polytec PT GmbH Polymere Technologien.

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

Arkema S.A. Appoints Florence Lambert and Séverin Cabannes as Director

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

Upcoming dividend of €3.40 per share at 3.9% yield

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 11%, revenue upgraded

Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Full year 2022 earnings: EPS misses analyst expectations

Arkema S.A. Announces Executive Changes

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Prayon S.A. completed the acquisition of Febex S.A from Arkema S.A. (ENXTPA:AKE).

Arkema S.A. to Report Q1, 2023 Results on May 05, 2023

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Prayon S.A. entered into an agreement to acquire Febex S.A from Arkema S.A. (ENXTPA:AKE).

Price target decreased to €104

Price target decreased to €106

At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Arkema S.A. (ENXTPA:AKE) acquired Polimeros Especiales, S.A. De C.V.

Arkema S.A. to Report Fiscal Year 2022 Results on Feb 23, 2023